PhaseRx News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

14.12.17	Global Tall Oil Fatty Acid Market 2017-2021: Latest Trend Gaining Momentum in the Market is Increasing Use in Rubber Industry (PR Newswire)
13.12.17	PhaseRx Receives Decision from the Nasdaq Hearings Panel for Continued Listing of Shares (PR Newswire)
11.12.17	PhaseRx To Voluntary File For Chapter 11 Bankruptcy Protection - Quick Facts (RTTNews)
11.12.17	PhaseRx Commences Voluntary Chapter 11 Bankruptcy Protection Proceeding (PR Newswire)
28.11.17	PhaseRx Receives Positive Opinion for Orphan Drug Designation for PRX-ASL from European Medicines Agency (PR Newswire)
09.11.17	PhaseRx Reports Third Quarter 2017 Financial Results and Provides Corporate Update (PR Newswire)
31.10.17	PhaseRx to Present at 5th International mRNA Conference (PR Newswire)
27.10.17	PhaseRx Receives Delisting Notice from Nasdaq and Evaluates Listing Options (PR Newswire)
13.10.17	PhaseRx Announces Corporate Restructuring and Review of Strategic Alternatives (PR Newswire)
20.09.17	PhaseRx Receives Orphan Drug Designation from FDA for PRX-ASL for the Treatment of Argininosuccinate Lyase Deficiency (PR Newswire)
10.08.17	PhaseRx Reports Second Quarter 2017 Financial Results and Provides Corporate Update (PR Newswire)
12.05.17	PhaseRx Reports First Quarter 2017 Financial Results and Provides Corporate Update (PR Newswire)
03.05.17	PhaseRx to Present Data at the American Society of Gene & Cell Therapy 20th Annual Meeting (PR Newswire)
27.04.17	PhaseRx to Present Data at the TIDES Conference (PR Newswire)
27.04.17	Gainers & Losers Of Apr.26: AKBA, FLKS, BIOL, BABY, FLXN... (RTTNews)
25.04.17	PhaseRx Receives Positive Opinion for Orphan Drug Designation for PRX-OTC from European Medicines Agency (PR Newswire)
25.04.17	Gainers & Losers Of Apr.24: PZRX, BCR, IMNP, ACHN, AKTX... (RTTNews)
27.03.17	PhaseRx Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update (PR Newswire)
22.03.17	Research Reports Initiation on Biotech Stocks -- Radius Health, Acorda, PhaseRx, and Athersys (PR Newswire)
27.02.17	PhaseRx to Present at Upcoming Investor Conferences (PR Newswire)
08.02.17	PhaseRx to Present Data for PRX-OTC at the 13th Annual WORLDSymposium™ 2017 (PR Newswire)
07.02.17	Research Reports Coverage on Biotech Stocks -- Inovio Pharma, Intra-Cellular Therapies, PhaseRx, and Global Blood Therapeutics (PR Newswire)
04.01.17	PhaseRx to Present at Biotech Showcase 2017 (PR Newswire)
16.12.16	Research Reports Coverage on Biotech Stocks -- Idera Pharma, bluebird bio, Corcept Therapeutics, and PhaseRx (PR Newswire)
28.11.16	PhaseRx Receives Orphan Drug Designation from FDA for PRX-OTC for the Treatment of Ornithine Transcarbamylase Deficiency (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Logitech Intl	79.18	1.64 %	K V
CieFinRichemont	140.20	1.26 %	K V
Swiss Re	132.30	0.92 %	K V
Swiss Life Hldg	707.40	0.91 %	K V
Zurich Insur Gr	529.40	0.80 %	K V
Roche Hldg G	263.40	-0.57 %	K V
Kuehne+Nagel Int	200.00	-0.65 %	K V
Novartis	90.11	-0.75 %	K V
Givaudan	3’848.00	-0.95 %	K V
Lonza Grp	537.40	-1.29 %	K V

Nachrichten zu PhaseRx Inc

Aktien Top/Flop

Meistgelesene Nachrichten